[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f5-cFwjavqhh-W_K_elD3KCl2rZ0vUvahzaxTeFtTdY0":8,"$fPtk14s1u0TkjWnV-BpHsvxzRaappDFWWuLUH8D_s1zU":55,"$fuA8Da6NIEcKXd6TSlIJGRbxmOu6hp7pJraMIRPBPfdI":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},70320,863254,[],"https://ystcdn.venuertc.com/medical/ystApp/Dlmj9URvs7gXdepZpARivDbqwZwkg06p.png","朱永亮","龙口南山养生谷肿瘤医院","放射科","住院医师",397,0,"结肠癌晚期常用药物：安全用药全指南 💊","","https://ystcdn.venuertc.com/venue/AI/d036d0ce-5a9a-4e9f-bc44-75a4a7abc04d.jpg","\u003Cdiv class=\"drug-guide-wrapper\">\n  \u003Ch1 id=\"material_title\" class=\"drug-guide-title\">\n    结肠癌晚期常用药物：安全用药全指南 💊\n  \u003C/h1>\n  \u003Cdiv class=\"drug-guide-intro drug-guide-bg1\">\n    说起晚期结肠癌的治疗药物，很多人第一反应是化疗和靶向药。它们是肠道肿瘤治疗的重要工具，却各有特点和注意事项。今天我们就围绕奥沙利铂、卡培他滨和贝伐珠单抗这三种常见药物，梳理8个关键实用细节，帮助您在安全用药的路上少走弯路。\n  \u003C/div>\n  \n  \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg2\">01 药品成分与剂型 👩‍🔬\u003C/h2>\n  \u003Cdiv class=\"drug-guide-section\">\n    \u003Cstrong>1. 奥沙利铂（Oxaliplatin）\u003C/strong>：主要成分为奥沙利铂，是一种含铂类的静脉注射化疗药，通常以注射液形式供应。规格有50mg、100mg等多种包装。\u003Cbr>\n    \u003Cstrong>2. 卡培他滨（Capecitabine）\u003C/strong>：是一种口服氟嘧啶类药物。有150mg或500mg的片剂，适合分次口服。\u003Cbr>\n    \u003Cstrong>3. 贝伐珠单抗（Bevacizumab）\u003C/strong>：属于人源化单克隆抗体，常见为注射剂型，规格为100mg/4ml、400mg/16ml等。\n  \u003C/div>\n  \n  \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg3\">02 药物作用机制：为什么它们管用？\u003C/h2>\n  \u003Cdiv class=\"drug-guide-section\">\n    \u003Cstrong>奥沙利铂\u003C/strong>通过与DNA结合，阻断癌细胞自我修复和复制，从而达到抑制肿瘤细胞生长的目的（Pang et al., 2019）。\u003Cbr>\n    \u003Cstrong>卡培他滨\u003C/strong>则在体内转化为活性形式5-FU，干扰DNA和RNA的合成，限制异常细胞增殖（Miwa et al., 1998）。\u003Cbr>\n    \u003Cstrong>贝伐珠单抗\u003C/strong>的机制是阻断血管生成因子VEGF，防止肿瘤建立新的血管供应，从而\"饿死\"癌细胞（Ferrara et al., 2004）。这些机制决定了药效和不良反应的类型，但一旦过量或和部分药物合用，风险更高。\n  \u003C/div>\n  \n  \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg4\">03 服药时间、方式与技巧 🕰️\u003C/h2>\n  \u003Cdiv class=\"drug-guide-section\">\n    \u003Cstrong>奥沙利铂\u003C/strong>：\u003Cbr>\n    · 必须通过静脉输注，不能口服或肌注。\u003Cbr>\n    · 输注时间不少于2小时。\u003Cbr>\n    \u003Cspan class=\"drug-guide-tips\">正确做法：\u003C/span>化疗当天不饮酒，输液当天穿宽松衣服。\u003Cbr>\u003Cbr>\n    \u003Cstrong>卡培他滨\u003C/strong>：\u003Cbr>\n    · 建议在餐后30分钟内用足量温水吞服，不要咀嚼或掰开（即使片剂很大也不要掰碎）。\u003Cbr>\n    · 按医嘱分早晚两次服用，尽量每天同一时间。\u003Cbr>\n    \u003Cspan class=\"drug-guide-tips\">正确做法：\u003C/span>漏服6小时内可补服，超过6小时直接跳过，不要多服。\u003Cbr>\u003Cbr>\n    \u003Cstrong>贝伐珠单抗\u003C/strong>：\u003Cbr>\n    · 通常静脉输注，每次至少90分钟以上，第1~2次需延长监测时间，主要看过敏反应。\u003Cbr>\n    \u003Cspan class=\"drug-guide-tips\">需要注意：\u003C/span>使用期间严格监控血压，输注当日安排充分休息和水分补充。\n  \u003C/div>\n  \n  \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg5\">04 剂量调整与特殊人群用药 🤔\u003C/h2>\n  \u003Cdiv class=\"drug-guide-section\">\n    \u003Cspan class=\"drug-guide-strong\">奥沙利铂\u003C/span>：\u003Cbr>\n    · 患有肝功能不全或出现明显神经毒性时，需要减少剂量或暂停用药。\u003Cbr>\n    · 老年人常需要根据肾功能评估再确定剂量，不能盲目照搬普通成人剂量。\u003Cbr>\u003Cbr>\n    \u003Cspan class=\"drug-guide-strong\">卡培他滨\u003C/span>：\u003Cbr>\n    · 肾功能不全、70岁以上、体重偏轻患者剂量要个体化。起始剂量过高容易增加副作用。\u003Cbr>\n    · 孕妇与哺乳期禁用。\u003Cbr>\u003Cbr>\n    \u003Cspan class=\"drug-guide-strong\">贝伐珠单抗\u003C/span>：\u003Cbr>\n    · 有脑出血、高血压未控者应避免使用。\u003Cbr>\n    · 妊娠期及哺乳期严禁使用。如需用药，务必避孕。\n    \u003Cdiv class=\"drug-guide-case\">\n      \u003Cspan class=\"drug-guide-icon\">📝\u003C/span>\n      一位老年女性接受奥沙利铂静脉输注过程中因肝功能不全调整了剂量，避免了严重不良反应。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg6\">05 药物相互作用：这些组合要小心 ⚠️\u003C/h2>\n  \u003Cdiv class=\"drug-guide-section\">\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>\u003Cstrong>奥沙利铂\u003C/strong>和含铝、镁制酸药冲突（可能影响药物代谢），合用时需隔开用药时间或改用其他药物。\u003C/li>\n      \u003Cli>\u003Cstrong>卡培他滨\u003C/strong>不能和华法林等抗凝药同用，否则易引发出血风险。如必须合用，需密切监测凝血功能（Cassidy et al., 2002）。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗\u003C/strong>和其他抗肿瘤药物合用时要评估心血管不良反应风险。高血压患者慎用ACEI/ARB类降压药与贝伐珠单抗同用。\u003C/li>\n      \u003Cli>不要随意加用草药、保健品，可能与药物代谢酶产生交互，影响疗效。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"drug-guide-tips\">正确做法：\u003C/span>凡新加或停用一种药，需向医生或药师报备，避免潜在风险。\n  \u003C/div>\n\n  \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg1\">06 常见不良反应及识别处理 🚨\u003C/h2>\n  \u003Cdiv class=\"drug-guide-section\">\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>\n        \u003Cspan class=\"drug-guide-strong\">奥沙利铂：\u003C/span>低温诱发性手麻、喉部异物感较为典型，输注后注意手脚保暖，减少接触冷水和冰食。还可能出现白细胞减少，务必按时查血。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"drug-guide-strong\">卡培他滨：\u003C/span>最常见是手足红肿脱皮和口腔炎，部分人还会有腹泻。每日检查手脚皮肤，如红肿发亮，及时用保湿剂。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"drug-guide-strong\">贝伐珠单抗：\u003C/span>高血压和蛋白尿需警惕。服药期间按周自测血压，出现明显下肢浮肿、泡沫尿请及时就医。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"drug-guide-tips\">出现持续发热、持续腹泻、无法耐受的口腔溃疡等，务必暂停用药并迅速就医。\u003C/span>\n    \u003Cdiv class=\"drug-guide-case\">\n      \u003Cspan class=\"drug-guide-icon\">📝\u003C/span>\n      临床实践表明，规范监测血常规和肝肾功能，可显著减少奥沙利铂及卡培他滨的不良反应停药事件。\n    \u003C/div>\n    \u003Cspan class=\"drug-guide-data\">临床数据显示，奥沙利铂相关手麻发生率约60%，卡培他滨腹泻和手足综合征各占受试者20%以上（Cassidy et al., 2002）。\u003C/span>\n  \u003C/div>\n  \n  \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg3\">07 储存和有效期，如何保存不出错 📦\u003C/h2>\n  \u003Cdiv class=\"drug-guide-section\">\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>注射剂型（如奥沙利铂、贝伐珠单抗）应密封避光，存放于2～8℃的冰箱冷藏室，不可冷冻。\u003C/li>\n      \u003Cli>卡培他滨片剂需密封阴凉干燥保存（20～25℃为宜），避免潮湿和高温。\u003C/li>\n      \u003Cli>所有药物开封后注意保质期，剩余药液或未服完的片剂避免与他人共用或回收。\u003C/li>\n      \u003Cli>过期或不用的化疗药品应带原包装送至医院药房回收，不要随意丢弃，以免造成环境污染。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"drug-guide-tips\">正确做法：\u003C/span>开封后的药品如发现颜色或澄清度异常，应暂停使用并咨询药师。\n  \u003C/div>\n  \n  \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg2\">08 漏服和过量了怎么办？📘\u003C/h2>\n  \u003Cdiv class=\"drug-guide-section\">\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>\u003Cstrong>奥沙利铂、贝伐珠单抗\u003C/strong>：如因故错过输液，只能联系医生预约下一次调整，切忌自行增减剂量或在家自行补药。\u003C/li>\n      \u003Cli>\u003Cstrong>卡培他滨\u003C/strong>：漏服6小时内可补服一次。超过6小时不需补服，直接按下一个用药时间服。切勿自行双倍服用。\u003C/li>\n      \u003Cli>服药过量后如有不适，务必第一时间联系急诊科，有条件者携带药盒和余药。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"drug-guide-tips\">出现明显不适，如恶心持续、手麻加重、出血点大量出现时，请马上停药并就医。\u003C/span>\n    \u003Cdiv class=\"drug-guide-case\">\n      \u003Cspan class=\"drug-guide-icon\">📝\u003C/span>\n      有位患者一次服用多片卡培他滨后出现极度乏力，医院及时处理未造成后果。用药期间严格遵守医嘱非常重要。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg4\">09 用药总结：牢记这些细节更安心 💯\u003C/h2>\n  \u003Cdiv class=\"drug-guide-section\">\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>明确用药类型与剂量，遵医嘱分时段、分剂型使用药品。\u003C/li>\n      \u003Cli>重点关注药物相互作用，遇到新加药或调整剂量时及时告知医生。\u003C/li>\n      \u003Cli>服药期间认真监测常见不良反应，出现异常随时就医。\u003C/li>\n      \u003Cli>规范保存药物，避免潮湿变质，药品到期及时回收处理。\u003C/li>\n      \u003Cli>每次用药如有疑问，及时与专业药师沟通，不可随意变更用药方案。\u003C/li>\n    \u003C/ul>\n    这三种药品各有优势和风险，找到适合自己的服用方法、密切关注身体变化，是保护健康的关键措施。记住，安全用药才是真正的有效治疗基础。\n  \u003C/div>\n  \u003Cdiv class=\"drug-guide-references\">\n    \u003Cspan class=\"drug-guide-strong\">引用文献：\u003C/span>\n    \u003Cul>\n      \u003Cli>Pang, L., et al. (2019). \"Oxaliplatin-induced neurotoxicity: Clinical features, mechanisms and prevention strategies.\" Cancer Letters, 460: 72–81.\u003C/li>\n      \u003Cli>Miwa, M., et al. (1998). \"Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.\" European Journal of Cancer, 34(8): 1274-1281.\u003C/li>\n      \u003Cli>Ferrara, N., et al. (2004). \"The biology of VEGF and its receptors.\" Nature Medicine, 10(6): 669-676.\u003C/li>\n      \u003Cli>Cassidy, J., et al. (2002). \"Capecitabine (Xeloda®): a review of efficacy and safety.\" Cancer Treatment Reviews, 28(2): 69-89.\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.drug-guide-wrapper {\n  max-width: 700px;\n  margin: 30px auto 30px auto;\n  font-family: \"Helvetica Neue\", Helvetica, Arial, \"Microsoft YaHei\", sans-serif;\n  background: #fc;\n  box-shadow: 0 2px 10px rgba(30,30,50,0.05);\n  border-radius: 18px;\n  padding: 32px 28px 30px 28px;\n  color: #28344b;\n  line-height: 1.95;\n  font-size: 18px;\n}\n.drug-guide-title {\n  text-align: center;\n  font-size: 2.5rem;\n  margin-bottom: 38px;\n  letter-spacing: 1.5px;\n  color: #1A3A6A;\n  font-family: \"PingFang SC\", \"Helvetica Neue\", Arial, \"Microsoft YaHei\", sans-serif;\n  font-weight: 700;\n}\n.drug-guide-subtitle {\n  margin-top: 44px;\n  margin-bottom: 18px;\n  padding: 20px 16px 14px 35px;\n  font-size: 1.67rem;\n  color: #20446b;\n  border-radius: 10px 10px 0 0;\n  font-weight: 600;\n  background-size: cover;\n  background-repeat: no-repeat;\n}\n\n.drug-guide-bg1 {\n  background: linear-gradient(100deg, #e5ecef 0%, #f5fafd 100%);\n}\n.drug-guide-bg2 {\n  background: linear-gradient(120deg, #f5fafd 0%, #e5ecef 90%);\n}\n.drug-guide-bg3 {\n  background: linear-gradient(80deg, #dceff7 0%, #fafdfe 100%);\n}\n.drug-guide-bg4 {\n  background: linear-gradient(120deg, #f7fdee 0%, #d2eb 100%);\n}\n.drug-guide-bg5 {\n  background: linear-gradient(100deg, #f8ede3 0%, #eaf3ec 100%);\n}\n.drug-guide-bg6 {\n  background: linear-gradient(110deg, #f6eefa 0%, #e2eafb 100%);\n}\n\n.drug-guide-intro {\n  margin-bottom: 38px;\n  padding: 18px 20px 16px 28px;\n  background: linear-gradient(90deg, #dde7ed 60%, #f6fafd 100%);\n  border-radius: 13px;\n  font-size: 1.13em;\n  color: #205070;\n  font-weight: 500;\n  border-left: 7px solid #87afb9;\n}\n\n.drug-guide-section {\n  background-color: #f8fafc;\n  border-radius: 0 0 12px 12px;\n  padding: 22px 23px 22px 30px;\n  margin-bottom: 10px;\n  box-shadow: 0 1px 5px rgba(200, 220, 240, 0.08);\n  font-size:1.05em;\n  min-height: 54px;\n  position:relative;\n}\n\n.drug-guide-list {\n  list-style: disc inside;\n  margin: 0 0 0 0.7em;\n  padding: 0;\n  font-size: 1em;\n}\n.drug-guide-list li {\n  margin-bottom: 11px;\n}\n.drug-guide-tips {\n  display:inline-block;\n  margin-top:8px;\n  margin-bottom: 6px;\n  color: #428a78;\n  font-weight:600;\n  font-size: 1.04em;\n}\n.drug-guide-strong {\n  color: #1978b6;\n  font-weight: 600;\n}\n.drug-guide-case {\n  background: #f8f1e2;\n  color: #815b3f;\n  font-size: 0.96em;\n  border-left: 5px solid #ebc07a;\n  border-radius: 6px;\n  padding: 10px 16px 10px 35px;\n  margin-top: 18px;\n  margin-bottom: 5px;\n  position: relative;\n}\n.drug-guide-case .drug-guide-icon {\n  font-size: 1.17em;\n  position: absolute;\n  left: 10px;\n  top: 9px;\n}\n.drug-guide-data {\n  display: block;\n  margin-top: 16px;\n  color: #bb781d;\n  font-size: 0.97em;\n  font-family: \"Menlo\", \"Consolas\", \"monospace\", serif;\n}\n.drug-guide-references {\n  margin-top: 24px;\n  border-top: 1px dashed #d3d4d6;\n  padding-top: 20px;\n  color: #627c98;\n  font-size: 15px;\n  background: linear-gradient(90deg,#f1f6fa 70%,#f6f8fa 100%);\n  border-radius: 8px;\n}\n.drug-guide-references ul {\n  margin-left: 2em;\n  padding-left: 0;\n}\n\u003C/style>","\u003Cdiv class=\"drug-guide-wrapper\">\n  \u003Ch1 id=\"material_title\" class=\"drug-guide-title\">\n    结肠癌晚期常用药物：安",257,"2025-11-04 01:51:32","结肠癌, 奥沙利铂, 卡培他滨, 贝伐珠单抗, 安全用药, 不良反应, 化疗药物, 晚期肠癌","了解奥沙利铂、卡培他滨和贝伐珠单抗的使用方法、注意事项和不良反应，这些关键信息能帮助患者安全用药，提升治疗效果。","2025-12-03 21:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]